Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to evaluate the added value of intensive self-monitoring of blood glucose (SMBG), structured in timing and frequency, in noninsulin-treated patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: The 12-month, randomized, clinical trial enrolled 1,024 patients with noninsulin-treated type 2 diabetes (median baseline HbA1c, 7.3% [IQR, 6.9-7.8%]) at 39 diabetes clinics in Italy. After standardized education, 501 patients were randomized to intensive structured monitoring (ISM) with 4-point glycemic profiles (fasting, preprandial, 2-h postprandial, and postabsorptive measurements) performed 3 days/week; 523 patients were randomized to active control (AC) with 4-point glycemic profiles performed at baseline and at 6 and 12 months. Two primary end points were tested in hierarchical order: HbA1c change at 12 months and percentage of patients at risk target for low and high blood glucose index. RESULTS: Intent-to-treat analysis showed greater HbA1c reductions over 12 months in ISM (-0.39%) than in AC patients (-0.27%), with a between-group difference of -0.12% (95% CI, -0.210 to -0.024; P=0.013). In the per-protocol analysis, the between-group difference was -0.21% (-0.331 to -0.089; P=0.0007). More ISM than AC patients achieved clinically meaningful reductions in HbA1c (>0.3, >0.4, or >0.5%) at study end (P<0.025). The proportion of patients reaching/maintaining the risk target at month 12 was similar in ISM (74.6%) and AC (70.1%) patients (P=0.131). At visits 2, 3, and 4, diabetes medications were changed more often in ISM than in AC patients (P<0.001). CONCLUSIONS: Use of structured SMBG improves glycemic control and provides guidance in prescribing diabetes medications in patients with relatively well-controlled noninsulin-treated type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Second, we excluded from our meta-analyses one RCT, which we determined to be a comparative effectiveness trial (i.e. comparing two sSMBG arms), despite the original authors describing an “active control” (58, 59).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
Nathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., & Zinman, B. (2006) · Diabetes Care · doi:10.2337/dc06-9912 · Cited by 1,203
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.9.725 · Cited by 509
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429 · cited 1×
“However, recent studies utilizing SMBG as an integral component of diabetes care showed improvements in mean glucose (8–12), glycemic variability (8), metabolic risk factors (10), depression and diabetes-related distress (13), and health behaviors (10–12).”
BackgroundFarmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., & Neil, A. (2007) · BMJ · doi:10.1136/bmj.39247.447431.be · Cited by 407
Riddle, M. C., Ambrosius, W. T., Brillon, D. J., Buse, J. B., Byington, R. P., Cohen, R. M., Goff, D. C., Malozowski, S., Margolis, K. L., Probstfield, J. L., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1278 · Cited by 406
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Trento, M., Passera, P., Borgo, E., Tomalino, M., Bajardi, M., Cavallo, F., & Porta, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.670 · Cited by 328
O’Kane, M. J., Bunting, B., Copeland, M., & Coates, V. E. (2008) · BMJ · doi:10.1136/bmj.39534.571644.be · Cited by 326
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L. A., Young-Hyman, D., Schlundt, D., & Clarke, W. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1870 · Cited by 310
Statistical handling of drop‐outs in longitudinal clinical trials
Heyting, A., Tolboom, J. T. B. M., & Essers, J. G. A. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111603 · Cited by 238
Lower Baseline Glycemia Reduces Apparent Oral Agent Glucose-Lowering Efficacy
Bloomgarden, Z. T., Dodis, R., Viscoli, C. M., Holmboe, E. S., & Inzucchi, S. E. (2006) · Diabetes Care · doi:10.2337/dc06-1120 · Cited by 219
Davidson, M. B., Castellanos, M., Kain, D., & Duran, P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.006 · Cited by 178
DURÁN, A., MARTÍN, P., RUNKLE, I., PÉREZ, N., ABAD, R., FERNÁNDEZ, M., DEL VALLE, L., SANZ, M. F., & CALLE‐PASCUAL, A. L. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00081.x · Cited by 156
Kovatchev, B. P., Cox, D. J., Kumar, A., Gonder-Frederick, L., & Clarke, W. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322527021 · Cited by 146
Death during intensive glycemic therapy of diabetes: mechanisms and implications
Cryer, P. E. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.08.008 · Cited by 137 · cited 1×
“Provided the growing concerns for the increased mortality in intensively managed type 2 diabetes (35,36), the detection of asymptomatic hypoglycemia may be an additional advantage of structured SMBG.”
BackgroundFranciosi, M., Lucisano, G., Pellegrini, F., Cantarello, A., Consoli, A., Cucco, L., Ghidelli, R., Sartore, G., Sciangula, L., Nicolucci, A., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03268.x · Cited by 137
Self-citationKovatchev, B. P., Straume, M., Cox, D. J., & Farhy, L. S. (2000) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273660008833060 · Cited by 125
Slow response to loss of glycemic control in type 2 diabetes mellitus.
Brown, J. B., & Nichols, G. A. (2003) · PubMed · Cited by 112
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Axel-Schweitzer, M., Petersen, B., & Wagner, R. S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0073 · Cited by 85
Kovatchev, B. P., Cox, D. J., Gonder-Frederick, L., & Clarke, W. L. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502760098438 · Cited by 84
Structure and Correlates of Diabetes-Specific Locus of Control
Peyrot, M., & Rubin, R. R. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.994 · Cited by 78
Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients
Polonsky, W. H., & Fisher, L. (2013) · Diabetes Care · doi:10.2337/dc12-0731 · Cited by 77
Consensus Report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose
Klonoff, D. C., Bergenstal, R., Blonde, L., Boren, S. A., Church, T. S., Gaffaney, J., Jovanovič, L., Kendall, D. M., Kollman, C., Kovatchev, B. P., et al. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200612 · Cited by 74
Results that matter: Structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes
Parkin, C. G., Buskirk, A., Hinnen, D. A., & Schweitzer, M. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.03.002 · Cited by 71
Trento, M., Tomelini, M., Basile, M., Borgo, E., Passera, P., Miselli, V., Tomalino, M., Cavallo, F., & Porta, M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02319.x · Cited by 71
Kempf, K., Kruse, J., & Martin, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0008 · Cited by 66
Prato, S. D., LaSalle, J. R., Matthaei, S., Bailey, C. J., & Management, O. B. O. T. G. P. F. E. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02227.x · Cited by 66
Nicolucci, A., Rossi, M. C., Arcangeli, A., Cimino, A., De Bigontina, G., Fava, D., Gentile, S., Giorda, C., Meloncelli, I., Pellegrini, F., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03055.x · Cited by 65
Self-citationSelf-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients
Malanda, U. L., Bot, S. D., & Nijpels, G. (2013) · Diabetes Care · doi:10.2337/dc12-0831 · Cited by 65
Bonomo, K., De Salve, A., Fiora, E., Mularoni, E., Massucco, P., Poy, P., Pomero, A., Cavalot, F., Anfossi, G., & Trovati, M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.021 · Cited by 53
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Welschen, L. M., Bloemendal, E., Nijpels, G., Dekker, J. M., Heine, R. J., Stalman, W. A., & Bouter, L. M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub2 · Cited by 51
Fisher, L., Polonsky, W., Parkin, C. G., Jelsovsky, Z., Amstutz, L., & Wagner, R. S. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.619176 · Cited by 47
Scavini, M., Bosi, E., Ceriello, A., Giorgino, F., Porta, M., Tiengo, A., Vespasiani, G., Bottalico, D., Marino, R., Parkin, C., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-011-0357-y · Cited by 25
Self-citationShiraiwa, T., Takahara, M., Kaneto, H., Miyatsuka, T., Yamamoto, K., Yoshiuchi, K., Sakamoto, K., Matsuoka, T., Matsuhisa, M., Yamasaki, Y., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.022 · Cited by 20
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Self-citationLim, L. L., Lau, E. S. H., Kong, A. P. S., Davies, M. J., Levitt, N. S., Eliasson, B., Aguilar-Salinas, C. A., Ning, G., Seino, Y., So, W. Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2010 · Cited by 145
Mogre, V., Johnson, N., Tzelepis, F., Shaw, J. E., & Paul, C. L. (2019) · Journal of Advanced Nursing · doi:10.1111/jan.14190 · Cited by 144
Glycaemic management in diabetes: old and new approaches
Ceriello, A., Prattichizzo, F., Phillip, M., Hirsch, I. B., Mathieu, C., & Battelino, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00245-x · Cited by 139
Self-citationGreenwood, D. A., Blozis, S. A., Young, H. M., Nesbitt, T. S., & Quinn, C. C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4112 · Cited by 128
“The St Carlos [7], ROSSO [37], and PRISMA [17] studies also showed improvement in A 1c when structured SMBG data were used to adjust treatment.”
Metadata
- Authors
- Bosi, E., Scavini, M., Ceriello, A., Cucinotta, D., Tiengo, A., Marino, R., Bonizzoni, E., Giorgino, F., & on behalf of the PRISMA Study Group
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- University of Messina (IT)
- University of Padua (IT)
- Roche (Italy) (IT)
- University of Milan (IT)
- University of Bari Aldo Moro (IT)
- Corresponding author
- Bosi, Emanuele
- Giorgino, Francesco
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-09-14
- Volume
- 36
- Issue
- 10
- Pages
- 2887-2894
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3781531
- OpenAlex
- W2125091241
- Cited by
- 105
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 8 · 2016: 14 · 2015: 17 · 2014: 8 · 2013: 3
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, cc-by-nc-nd)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Use Siena air (University of Siena) (submittedVersion, cc-by-nc-nd)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- self-monitoring of blood glucose, type 2 diabetes, glycemic control, HbA1c, glycemic profile, hypoglycemia, hyperglycemia, patient education
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.